4.8 Review

Integrated Approach to Structure-Based Enzymatic Drug Design: Molecular Modeling, Spectroscopy, and Experimental Bioactivity

期刊

CHEMICAL REVIEWS
卷 114, 期 1, 页码 493-537

出版社

AMER CHEMICAL SOC
DOI: 10.1021/cr300314q

关键词

-

资金

  1. National Research Foundation (NRF)
  2. UKZN
  3. Aspen-Pharmacare

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Deciphering the molecular mechanisms of selective non-covalency demonstrated differentially by 9-Allylnaphtho[1,8-ef]isoindole-7,8,10(9H)-trione (C11) against fibroblast growth factor receptors 1-4

Fisayo A. Olotu, Mahmoud E. S. Soliman

Summary: The selective inhibition of aberrant Fibroblast Growth Factor Receptors (FGFRs) is a viable strategy for cancer treatment. A recent study discovered a new compound C11 that showed selective activity against FGFR1. Computational methods were used to investigate the mechanism of this selective activity. This study provides rational insights for the structure-based design of highly specific FGFR1 inhibitors.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Article Biochemistry & Molecular Biology

Meta-Analysis and Multivariate GWAS Analyses in 77,850 Individuals of African Ancestry Identify Novel Variants Associated with Blood Pressure Traits

Brenda Udosen, Opeyemi Soremekun, Abram Kamiza, Tafadzwa Machipisa, Cisse Cheickna, Olaposi Omotuyi, Mahmoud Soliman, Mamadou Wele, Oyekanmi Nashiru, Tinashe Chikowore, Segun Fatumo

Summary: High blood pressure is a major risk factor for cardiovascular diseases in populations including individuals of African ancestry. However, limited genetic studies have been conducted to explore the genetic mechanism driving this phenomenon. This study performed genome-wide association analyses and identified independent genetic variants associated with blood pressure traits in individuals of African ancestry. The findings provide important insights into the molecular mechanisms underlying the genetics of blood pressure and have implications for further research and fine-mapping of high-risk loci/variants.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Pharmacophore-based virtual screening and in-silico study of natural products as potential DENV-2 RdRp inhibitors

Miah Roney, A. K. M. Moyeenul Huq, Abdul Rashid Issahaku, Mahmoud E. S. Soliman, Md. Sanower Hossain, Abu Hasnat Mustafa, Md. Alimul Islam, Amit Dubey, Aisha Tufail, Mohd Fadhlizil Fasihi Mohd Aluwi, Saiful Nizam Tajuddin

Summary: Dengue fever is a significant global public health concern, causing hundreds of thousands of hospitalizations and deaths each year. This study aimed to discover a new anti-dengue therapy by using computer-based approaches. Natural products were screened using a pharmacophore model, and compounds with potential inhibitory effects were identified through molecular docking. The lead compound demonstrated promising characteristics for further development as a drug candidate.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Article Virology

Chetomin, a SARS-CoV-2 3C-like Protease (3CLpro) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis

Mahmoud A. A. Ibrahim, Alaa H. M. Abdelrahman, Dina E. M. Mohamed, Khlood A. A. Abdeljawaad, Mohamed Ahmed Naeem, Gamal A. Gabr, Ahmed M. Shawky, Mahmoud E. S. Soliman, Peter A. Sidhom, Paul W. Pare, Mohamed-Elamir F. Hegazy

Summary: The COVID-19 pandemic caused by the SARS-CoV-2 virus has resulted in over 6 million deaths. Marine natural products have been explored as potential sources of antiviral drug candidates. Through screening and molecular docking, chetomin (UMHMNP1403367) was identified as a promising 3CL(pro) inhibitor for COVID-19 treatment. Further in vivo and in vitro studies are warranted to assess its efficacy.

VIRUSES-BASEL (2023)

Review Chemistry, Multidisciplinary

Reaction of 3-Acetylcoumarin: From methods to mechanism

Narges Hosseini Nasab, Fereshteh Azimian, Hendrik G. Kruger, Song Ja Kim

Summary: Coumarins, heterocyclic compounds with a benzo-a-pyrone structure, are widely used in pharmacology, cosmetics, chemical, and medicinal industries. Various methods and reactions have been employed to synthesize coumarin derivatives. This review covers the reactions of 3-acetylcoumarin with different reagents and provides an overview of various reactions of 3-acetylcoumarin, including multicomponent, cycloaddition, α-halogenation, aldol condensation, reduction, and 1,2-addition reactions. The synthesis of different compounds starting from 3-acetylcoumarins and their biological activities are presented. This review serves as a valuable resource for researchers in this field.

ARABIAN JOURNAL OF CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

Propitious Indazole Compounds as β-ketoacyl-ACP Synthase Inhibitors and Mechanisms Unfolded for TB Cure: Integrated Rational Design and MD Simulations

Adeniyi T. T. Adewumi, Wande M. M. Oluyemi, Yemi A. A. Adekunle, Nonhlanhla Adewumi, Mohamed Issa Alahmdi, Mahmoud E. S. Soliman, Nader E. E. Abo-Dya

Summary: This study identifies six novel inhibitors of the KasA enzyme, a critical target in TB drug design. The compounds JFX, M1, M2, and M5 show stronger interactions with KasA and have good predicted inhibitory constants, drug-likeness, ADME, and synthetic accessibility. The findings provide potential lead-like molecules for future TB drugs.

CHEMISTRYSELECT (2023)

Article Biochemistry & Molecular Biology

Intermolecular And Dynamic Investigation of The Mechanism of Action of Reldesemtiv on Fast Skeletal Muscle Troponin Complex Toward the Treatment of Impaired Muscle Function

Abdul Rashid Issahaku, Mahmoud A. A. Ibrahim, Namutula Mukelabai, Mahmoud E. S. Soliman

Summary: Muscle weakness is a common problem in patients with neurogenic neuromuscular diseases and leads to disability and even death. This study focuses on the investigation of Reldesemtiv, a second-generation small molecule activator, and its impact on fast skeletal muscle troponin complex through computational techniques. The results reveal that Reldesemtiv binding potentially enhances the compactness of troponin C, reducing exposure to solvent molecules and favoring the slow release of calcium ions, resulting in the sensitization of the subunit to calcium. Several key residues in the inhibitory subunit, including Arg113, Met116, Val114, and Met121, contribute significantly to the binding energy of Reldesemtiv. These findings provide valuable insights for the development of specific and potent small molecule activators for fast skeletal muscle.

PROTEIN JOURNAL (2023)

Article Chemistry, Organic

N-Arylation of primary and tertiary sulfonimidamides (SIAs) with benzyne precursors under transition metal-free conditions

Srinivas Ambala, Kimberleigh B. Govender, Kamal K. Rajbongshi, Thavendran Govender, Hendrik G. Kruger, Tricia Naicker, Per I. Arvidsson

Summary: Here, an effective and efficient transition metal-free method for the N-arylation of primary sulfonimidamides was reported. The benzyne intermediates generated from silyl aryl triflates successfully coupled with the primary sulfonimidamides, resulting in good to excellent yields. In addition, by adding 18-crown-6, the scope of this method was extended to tertiary sulfonimidamides with moderate to low yields.

TETRAHEDRON LETTERS (2023)

Article Chemistry, Medicinal

In Vitro and In Vivo Development of a β-Lactam-Metallo-β- Lactamase Inhibitor: Targeting Carbapenem-Resistant Enterobacterales

Byron K. Peters, Nakita Reddy, Mbongeni Shungube, Letisha Girdhari, Sooraj Baijnath, Sipho Mdanda, Lloyd Chetty, Thandokuhle Ntombela, Thilona Arumugam, Linda A. Bester, Sanil D. Singh, Anil Chuturgoon, Per I. Arvidsson, Glenn E. M. Maguire, Hendrik G. Kruger, Tricia Naicker, Thavendran Govender

Summary: Fi-lactams are the most commonly prescribed antibiotics due to their potent antimicrobial activities, but their efficacy is threatened by the alarming rates of antimicrobial resistance, particularly in carbapenem-resistant Enterobacterales expressing metallo-fi-lactamases (MBLs). In this study, a cyclic zinc chelator called BP1 was developed, which restored the efficacy of meropenem against MBL-expressing bacteria and showed no toxicity to human cells. The study also demonstrated the therapeutic potential of BP1 in reducing bacterial load in infected mice. These findings propose a promising strategy to combat antimicrobial resistance.

ACS INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Neutralizing Carbapenem Resistance by Co-Administering Meropenem with Novel fi-Lactam-Metallo- β-Lactamase Inhibitors

Nakita Reddy, Letisha Girdhari, Mbongeni Shungube, Arnoldus C. Gouws, Byron K. Peters, Kamal K. Rajbongshi, Sooraj Baijnath, Sipho Mdanda, Thandokuhle Ntombela, Thilona Arumugam, Linda A. Bester, Sanil D. Singh, Anil Chuturgoon, Per I. Arvidsson, Glenn E. M. Maguire, Hendrik G. Kruger, Thavendran Govender, Tricia Naicker

Summary: This study evaluated the use of a novel beta-lactamase inhibitor, BP2, in combination with meropenem to overcome resistance in hard-to-treat infectious diseases caused by virulent bacteria expressing beta-lactamases. The results showed that BP2 enhanced the activity of meropenem, exhibiting bactericidal effects with a MIC of <= 1 mg/L and was safe to use at the tested concentrations. BP2 also demonstrated strong inhibitory activity against NDM-1 and VIM-2, specifically targeting MBLs. In a murine infection model, the combination of BP2 and meropenem showed significant efficacy. These promising pre-clinical results make BP2 a suitable candidate for further research and development as a metallo-beta-lactamase inhibitor (MBLI).

ANTIBIOTICS-BASEL (2023)

Article Chemistry, Medicinal

Artificial Intelligence, Machine Learning, and Big Data for Ebola Virus Drug Discovery

Samuel K. Kwofie, Joseph Adams, Emmanuel Broni, Kweku S. Enninful, Clement Agoni, Mahmoud E. S. Soliman, Michael D. Wilson

Summary: This review explores the role of machine learning (ML) techniques, including Bayesian, support vector machine, random forest, and deep learning models, in predicting small molecule inhibitors of Ebola virus (EBOV). The underutilization of deep learning models in EBOV drug discovery is discussed, along with the potential of deep neural network as an ML algorithm for predicting anti-EBOV compounds. The importance of comprehensive data sources and the potential of ML-driven decision making in reducing compound attrition rates in drug development pipeline are highlighted.

PHARMACEUTICALS (2023)

Article Chemistry, Multidisciplinary

Design, synthesis, and in vitro and in silico studies of 1,3,4-thiadiazole-thiazolidinone hybrids as carbonic anhydrase inhibitors

Narges Hosseini Nasab, Hussain Raza, Young Seok Eom, Mubashir Hassan, Andrzej Kloczkowski, Lloyd Christopher Chetty, Hendrik Gert Kruger, Song Ja Kim

Summary: A series of 1,3,4-thiadiazole-thiazolidinone derivatives (7a-j) were synthesized and evaluated as carbonic anhydrase inhibitors. Compound 7i showed higher inhibitory activity (IC50 = 0.402 +/- 0.017 mu M) compared to the standard reference acetazolamide (IC50 = 0.998 +/- 0.046 mu M). Kinetic analysis revealed that compound 7i binds competitively to the target enzyme. Compound 7i also exhibited good conformational state and hydrogen bond interactions in the receptor binding pocket, according to molecular docking studies.

NEW JOURNAL OF CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

Synthesis and biological evaluation of novel blactam-metallo β-lactamase inhibitors

Mbongeni Shungube, Ayanda K. Hlophe, Letisha Girdhari, Victor T. Sabe, Byron B. Peters, Nakita Reddy, Kehinde F. Omolabi, Lloyd Chetty, Thilona Arumugam, Anil Chuturgoon, Hendrik G. Kruger, Per I. Arvidsson, Hua-Li Qin, Tricia Naicker, Thavendran Govender

Summary: Beta-lactamases deactivate beta-lactam antibiotics through hydrolysis mechanism. This study developed 11 potential MBL inhibitors that successfully restored the effectiveness of meropenem against NDM-producing Klebsiella pneumoniae infections.

RSC ADVANCES (2023)

暂无数据